N-nicotinoyltryptamine,
tryptamide,
Nicotredole,
29876-14-0,
N-(2-(1H-Indol-3-yl)ethyl)nicotinamide,
Tryptamide,
Nicotredole [INN],
N-Nicotinoyltryptamide,
N-3-Pyridoyltryptamine,
N-[2-(1H-indol-3-yl)ethyl]pyridine-3-carboxamide,
UNII-0F1T12OCLX,
N-[2-(1H-indol-3-yl)ethyl]nicotinamide,
C16H15N3O,
N-(2-(3-Indolyl)ethyl)-nicotinamide,
NSC 138472,
BRN 0242441,
0F1T12OCLX,
MLS000099033,
N-(2-Indol-3-ylethyl)nicotinamide,
N-(2-(1H-Indol-3-yl)ethyl)-3-pyridinecarboxamide,
Nicotinamide, N-(2-indol-3-ylethyl)-,
NCGC00061506-02,
SMR000070447,
N-[2-(1H-Indol-3-yl)-ethyl]-nicotinamide,
DSSTox_CID_25698,
DSSTox_RID_81070,
DSSTox_GSID_45698,
CAS-29876-14-0,
N-nicotinoyltryptamine,
Maybridge3_005451,
Opera_ID_1372,
N-(3-pyridoyl)tryptamine,
Oprea1_447719,
Oprea1_761339,
5-22-10-00125 (Beilstein Handbook Reference),
SCHEMBL735897,
3-Pyridinecarboxamide, N-(2-(1H-indol-3-yl)ethyl)-,
AC1L23X5,
ZINC4164,
CHEMBL1491339,
DTXSID8045698,
ZDAZUJBASMCUAK-UHFFFAOYSA-N,
HMS1446H17,
HMS2234B18,
HMS3370P19,
HMS3430H08,
KS-00000GT6,
Tox21_110977,
CCG-55266,
MFCD00841846,
N-[2-(3-indolyl)ethyl]nicotinamide,
NSC138472,
STK126937,
AKOS000554126,
Tox21_110977_1,
MCULE-3634300248,
NSC-138472,
IDI1_016838,
NCGC00061506-03,
AJ-08197,
AK-39297,
BAS 03049811,
BR-39297,
CJ-00094,
DS-13125,
LS-96438,
ZB000563,
AB0024044,
4CH-007581,
N-(2-indol-3-ylethyl)-3-pyridylcarboxamide,
ST24031291,
ST45171726,
W5233,
S-6678,
AF-833/36261002,
SR-01000475655-3,
Z26395443,
3-Pyridinecarboxamide, N-(2-(1H-indol-3-yl)ethyl)- (9CI),
CID65768,
C16-H15-N3-O,